Cargando…
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Despite recent advances in cancer therapeutics, glioblastoma (GBM) remains one of the most difficult cancers to treat in both the primary and recurrent settings. GBM presents a unique therapeutic challenge given the immune-privileged environment of the brain and the aggressive nature of the disease....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188021/ https://www.ncbi.nlm.nih.gov/pubmed/35690784 http://dx.doi.org/10.1186/s13045-022-01298-0 |